Publications by authors named "Mario Cioce"

Claim this Profile
D
Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade.
Andrea Marra, Alan Ramsay, Samuel Chamberlain-Keene, Gabriela Soares, Maurilio Ponzoni, Mario Cioce

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity.
Mario Cioce, Mariamena Arbitrio, Nicoletta Polerà, Emanuela Altomare, Antonia Rizzuto

Cancer Drug Resist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6.
Mario Cioce, Veronica Gatti, Fabiana Napolitano, Noemi Maria Giorgiano, Andrea Marra

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.
Claudio Pulito, Federica Mori, Andrea Sacconi, Frauke Goeman, Maria Ferraiuolo, Mario Cioce

Cell Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Mario Cioce, Maria Rita Fumagalli, Sara Donzelli, Frauke Goeman, Valeria Canu

J Exp Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy.
Gianluca Santamaria, Mario Cioce, Antonia Rizzuto, Vito Michele Fazio, Giuseppe Viglietto

Cancer Drug Resist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer Progression.
Mario Cioce, Andrea Marra, Daniela Rutigliano, Vito Michele Fazio

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.
Sara Donzelli, Mario Cioce, Andrea Sacconi, Francesca Zanconato, Theodora Daralioti

Mol Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?
Mario Cioce, Andrea Sacconi, Sara Donzelli, Claudia Bonomo, Letizia Perracchio

Comput Struct Biotechnol J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells.
Mario Cioce, Daniela Rutigliano, Annamaria Puglielli, Vito Michele Fazio

Cancer Drug Resist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma.
Mario Cioce, Claudia Canino, Harvey Pass, Giovanni Blandino, Sabrina Strano

J Exp Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature.
Mario Cioce, Andrea Sacconi, Harvey I Pass, Claudia Canino, Sabrina Strano

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
Mario Cioce, Vito Michele Fazio

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity.
Mario Cioce, Claudio Pulito, Sabrina Strano, Giovanni Blandino, Vito Michele Fazio

Cells· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma.
Tiziana Bruno, Francesca De Nicola, Giacomo Corleone, Valeria Catena, Frauke Goeman, Mario Cioce

Blood Adv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.
Simona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, Rossella Galati, Sabrina Strano, Mario Cioce

Oncogene· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.
Tania Frixa, Andrea Sacconi, Mario Cioce, Giuseppe Roscilli, Fabiana Fosca Ferrara

Carcinogenesis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.
Claudio Pulito, Federica Mori, Andrea Sacconi, Frauke Goeman, Maria Ferraiuolo, Mario Cioce

Cell Discov· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.
Valeria Canu, Andrea Sacconi, Laura Lorenzon, Francesca Biagioni, Federica Lo Sardo, Mario Cioce

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of Chemoresistant Cell Subpopulations.
Claudia Canino, Mario Cioce

Methods Mol Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.
Harvey I Pass, Carmencita Lavilla, Claudia Canino, Chandra Goparaju, Jordan Preiss, Mario Cioce

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or ...both?
Mario Cioce, Sabrina Strano, Paola Muti, Giovanni Blandino

Aging (Albany NY)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.
Sara Donzelli, Mario Cioce, Paola Muti, Sabrina Strano, Yosef Yarden

Semin Cell Dev Biol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.
Claudia Canino, YuYing Luo, Paola Marcato, Giovanni Blandino, Harvey I Pass, Mario Cioce

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.
Mario Cioce, MariaCristina Valerio, Luca Casadei, Claudio Pulito, Andrea Sacconi

Oncotarget· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis